FBR Capital reiterated a Market Perform rating and $10.00 price target on Keryx Biopharmaceuticals (NASDAQ: KERX) following recent financing. Keryx ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst EPS Change

Pre-Open Stock Movers 10/15: (FPRX) (BOFI) (DXCM) Higher; (IMPR) (MTW) (VRX) (STX) (GRMN) (HCA) (NFLX) Lower (more...)October 15, 2015 9:31 AM Keryx Biopharma (KERX) Announces $125M Private Placement of Conv. Notes with The Baupost GroupOctober 15, 2015 7:02 AM Keryx Biopharmaceuticals Announces $125 Million Private Placement of Convertible Senior Notes With The Baupost Group, L.L.C.October 15, 2015 7:00 AM